📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition. (2025)

First Author: Fey SK

Attributed to: Targeting radiation driven invasion and metastasis in cancers of unmet need funded by UKRI FLF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-23-2709

PubMed Identifier: 39412982

Publication URI: http://europepmc.org/abstract/MED/39412982

Type: Journal Article/Review

Volume: 85

Parent Publication: Cancer research

Issue: 2

ISSN: 0008-5472